Clinical Trial Update: Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing glutamine to prevent vaso-occlusive crises in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Ain Shams University | Conditions: Sickle Cell Disease | Phase 4 | Status: COMPLETED